Palmar plantar erythrodysesthesia physical examination: Difference between revisions
Tags: mobile edit mobile web edit |
|||
| (3 intermediate revisions by the same user not shown) | |||
| Line 16: | Line 16: | ||
===Vital Signs=== | ===Vital Signs=== | ||
*[[Vital signs]] are normal. | *[[Vital signs]] of [[patients]] with PPE are usually normal. | ||
===Skin=== | ===Skin=== | ||
*[[Skin]] [[examination]] of [[patients]] with PPE depends on the grade of the [[disease]]. Determination of [[toxicity]] grading of PPE requires both visual assessment and patient description of symptoms. | *[[Skin]] [[examination]] of [[patients]] with PPE depends on the grade of the [[disease]]. | ||
*Determination of [[toxicity]] grading of PPE requires both visual assessment and patient description of symptoms. | |||
* Physical findings include:<ref name="urlProtocol Development | CTEP">{{cite web |url=https://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm |title=Protocol Development | CTEP |format= |work= |accessdate=}}</ref> | * Physical findings include:<ref name="urlProtocol Development | CTEP">{{cite web |url=https://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm |title=Protocol Development | CTEP |format= |work= |accessdate=}}</ref> | ||
| Line 52: | Line 53: | ||
===Neuromuscular=== | ===Neuromuscular=== | ||
*[[Neuromuscular]] [[examination]] of [[patients]] with PPE is usually normal. Rarely, [[sensory]] [[impairment]] in the [[extremities]] may be seen. <ref name="pmid11034047">{{cite journal| author=Hui YF, Cortes JE| title=Palmar-plantar erythrodysesthesia syndrome associated with liposomal daunorubicin. | journal=Pharmacotherapy | year= 2000 | volume= 20 | issue= 10 | pages= 1221-3 | pmid=11034047 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11034047 }} </ref> <ref name="urlwww.oncologynurseadvisor.com">{{cite web |url=https://www.oncologynurseadvisor.com/home/departments/ce-courses/prevention-and-management-of-hand-foot-syndromes/ |title=www.oncologynurseadvisor.com |format= |work= |accessdate=}}</ref> | *[[Neuromuscular]] [[examination]] of [[patients]] with PPE is usually normal. | ||
*Rarely, [[sensory]] [[impairment]] in the [[extremities]] may be seen. <ref name="pmid11034047">{{cite journal| author=Hui YF, Cortes JE| title=Palmar-plantar erythrodysesthesia syndrome associated with liposomal daunorubicin. | journal=Pharmacotherapy | year= 2000 | volume= 20 | issue= 10 | pages= 1221-3 | pmid=11034047 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11034047 }} </ref> <ref name="urlwww.oncologynurseadvisor.com">{{cite web |url=https://www.oncologynurseadvisor.com/home/departments/ce-courses/prevention-and-management-of-hand-foot-syndromes/ |title=www.oncologynurseadvisor.com |format= |work= |accessdate=}}</ref> | |||
===Extremities=== | |||
*Extremities examination, excluding the neuromuscular and skin findings, in patients with PPE is usually normal. | |||
==References== | ==References== | ||
Latest revision as of 23:09, 17 July 2019
|
Palmar plantar erythrodysesthesia Microchapters |
|
Differentiating Palmar plantar erythrodysesthesia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Palmar plantar erythrodysesthesia physical examination On the Web |
|
American Roentgen Ray Society Images of Palmar plantar erythrodysesthesia physical examination |
|
FDA on Palmar plantar erythrodysesthesia physical examination |
|
CDC on Palmar plantar erythrodysesthesia physical examination |
|
Palmar plantar erythrodysesthesia physical examination in the news |
|
Blogs on Palmar plantar erythrodysesthesia physical examination |
|
Directions to Hospitals Treating Palmar plantar erythrodysesthesia |
|
Risk calculators and risk factors for Palmar plantar erythrodysesthesia physical examination |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mandana Chitsazan, M.D. [2]
Overview
Physical examination of patients with PPE depends on the grade of the disease. Determination of toxicity grading of PPE requires both visual assessment and patient description of symptoms. Skin findings include erythema, edema, hyperkeratosis, peeling, blisters, bleeding, and fissures.
Physical Examination
Physical examination of patients with PPE depends on the grade of the disease. Determination of toxicity grading of PPE requires both visual assessment and patient description of symptoms.
Appearance of the Patient
- Patients with PPE usually appear normal.
Vital Signs
- Vital signs of patients with PPE are usually normal.
Skin
- Skin examination of patients with PPE depends on the grade of the disease.
- Determination of toxicity grading of PPE requires both visual assessment and patient description of symptoms.
HEENT
- HEENT examination of patients with PPE is usually normal.
Neck
- Neck examination of patients with PPE is usually normal.
Lungs
- Pulmonary examination of patients with PPE is usually normal.
Heart
- Cardiovascular examination of patients with PPE is usually normal.
Abdomen
- Abdominal examination of patients with PPE is usually normal.
Back
- Back examination of patients with PPE is usually normal.
Genitourinary
- Genitourinary examination of patients with PPE is usually normal.
Neuromuscular
- Neuromuscular examination of patients with PPE is usually normal.
- Rarely, sensory impairment in the extremities may be seen. [2] [3]
Extremities
- Extremities examination, excluding the neuromuscular and skin findings, in patients with PPE is usually normal.
References
- ↑ "Protocol Development | CTEP".
- ↑ Hui YF, Cortes JE (2000). "Palmar-plantar erythrodysesthesia syndrome associated with liposomal daunorubicin". Pharmacotherapy. 20 (10): 1221–3. PMID 11034047.
- ↑ "www.oncologynurseadvisor.com".